BIIB FY 2016 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2016 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$11.4B+6.4% YoY

Gross Profit

$10.0B87.5% margin

Operating Income

$5.2B45.0% margin

Net Income

$3.7B32.3% margin

EPS (Diluted)

$16.93

Cash Flow

Operating Cash Flow

$4.5B

Free Cash Flow

$3.9B

Stock-Based Comp.

$155M

Balance Sheet

Total Assets

$22.9B

Total Liabilities

$10.7B

Stockholders' Equity

$12.1B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.4B	$10.8B	+6.4%
Gross Profit	$10.0B	$9.5B	+5.2%
Operating Income	$5.2B	$4.9B	+5.3%
Net Income	$3.7B	$3.5B	+4.4%